Literature DB >> 19732683

Epidemiology of locally advanced breast cancer.

Lisa A Newman1.   

Abstract

Locally advanced breast cancer refers to patients diagnosed with bulky primary cancers and/or regional adenopathy. It's frequency has diminished greatly because of screening mammography and early detection. However, impoverished and minority racial/ethnic communities continue to experience disproportionately high breast cancer mortality rates because of their high risk for being diagnosed with locally advanced disease.

Entities:  

Mesh:

Year:  2009        PMID: 19732683     DOI: 10.1016/j.semradonc.2009.05.003

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  27 in total

Review 1.  Management of locally advanced breast cancer-perspectives and future directions.

Authors:  Konstantinos Tryfonidis; Elzbieta Senkus; Maria J Cardoso; Fatima Cardoso
Journal:  Nat Rev Clin Oncol       Date:  2015-02-10       Impact factor: 66.675

2.  Fungating mass as first presentation of advanced breast cancer.

Authors:  Caroline E McCoach; Paul Aronowitz
Journal:  J Gen Intern Med       Date:  2013-09-25       Impact factor: 5.128

Review 3.  Indications for prognostic gene expression profiling in early breast cancer.

Authors:  Erin F Cobain; Daniel F Hayes
Journal:  Curr Treat Options Oncol       Date:  2015-05

4.  Factors influencing the outcome of breast cancer patients with 10 or more metastasized axillary lymph nodes.

Authors:  Jun Sang Lee; Seung Il Kim; So Young Choi; Hyung Seok Park; Jong Seok Lee; Seho Park; Jaseung Koo; Byeong-Woo Park; Kyong Sik Lee
Journal:  Int J Clin Oncol       Date:  2011-03-01       Impact factor: 3.402

5.  Role of plasma osteopontin as a biomarker in locally advanced breast cancer.

Authors:  Pieter H Anborgh; Laura Br Caria; Ann F Chambers; Alan B Tuck; Larry W Stitt; Muriel Brackstone
Journal:  Am J Transl Res       Date:  2015-04-15       Impact factor: 4.060

Review 6.  Meaningful prevention of breast cancer metastasis: candidate therapeutics, preclinical validation, and clinical trial concerns.

Authors:  Alexandra S Zimmer; Patricia S Steeg
Journal:  J Mol Med (Berl)       Date:  2014-11-22       Impact factor: 4.599

7.  Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer.

Authors:  Hauke Stamm; Leticia Oliveira-Ferrer; Eva-Maria Grossjohann; Jana Muschhammer; Vanessa Thaden; Franziska Brauneck; Roman Kischel; Volkmar Müller; Carsten Bokemeyer; Walter Fiedler; Jasmin Wellbrock
Journal:  Oncoimmunology       Date:  2019-10-12       Impact factor: 8.110

8.  Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.

Authors:  Emre Koca; Taha Y Kuzan; Omer Dizdar; Taner Babacan; Ilyas Sahin; Erhan Ararat; Kadri Altundag
Journal:  Med Oncol       Date:  2013-06-01       Impact factor: 3.064

Review 9.  T cell coinhibition and immunotherapy in human breast cancer.

Authors:  Murali Janakiram; Yael M Abadi; Joseph A Sparano; Xingxing Zang
Journal:  Discov Med       Date:  2012-10       Impact factor: 2.970

10.  Particle embolization to control life-threatening hemorrhage from a fungating locally advanced breast carcinoma: a case report.

Authors:  John M Moriarty; Minzhi Xing; Christopher T Loh
Journal:  J Med Case Rep       Date:  2012-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.